Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ERBA Diagnostics, Inc. (ERBA)
|
Add to portfolio |
|
|
|
| Price: |
$105.73
| | Metrics |
| OS: |
44.1
|
M
| |
-11
|
% ROE
|
| Market cap: |
$4.66
|
B
| |
-10
|
% ROIC
|
|
Net debt:
|
$1.9
|
M
| |
32.4
|
x Debt/EBITDA
|
|
EV:
|
$4.66
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$58.6
|
k
| |
79559.0
|
x EV/EBITDA
|
|
EBIT
|
($1.0)
|
M
| |
|
|
| EPS |
($0.04)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| Revenues | 26.4 | 28.3 | 19.3 | 16.8 | 17.0 | 18.4 | 20.8 | 20.0 |
| Revenue growth | -6.6% | 46.0% | 15.4% | -1.6% | -7.4% | -11.6% | 4.2% | 2.3% |
| Cost of goods sold | 13.8 | 14.4 | 10.3 | 8.2 | 8.2 | 8.3 | 8.4 | 8.4 |
| Gross profit | 12.6 | 13.8 | 9.1 | 8.6 | 8.8 | 10.1 | 12.4 | 11.6 |
| Gross margin | 47.8% | 48.9% | 47.0% | 51.3% | 51.8% | 54.9% | 59.7% | 58.0% |
| Sales and marketing | 4.0 | 5.3 | 4.6 | 5.1 | 4.9 | 5.6 | 4.9 | 5.5 |
| Research and development | 1.4 | 1.9 | 1.1 | 1.5 | 1.6 | 1.8 | 1.8 | 2.2 |
| General and administrative | 6.3 | 5.5 | 4.6 | 5.3 | 6.5 | 6.7 | 5.4 | 7.7 |
| EBITA | 1.2 | 1.2 | -1.3 | -3.2 | -4.2 | -4.3 | -0.2 | -11.3 |
| EBITA margin | 4.5% | 4.1% | -6.9% | -19.3% | -24.5% | -23.6% | -1.2% | -56.7% |
| Amortization of intangibles | 0.3 | 0.3 | 0.1 | | | | | |
| EBIT | 0.9 | 0.8 | -1.4 | -3.2 | -4.2 | -4.3 | -0.2 | -11.3 |
| EBIT margin | 3.3% | 2.9% | -7.3% | -19.3% | -24.5% | -23.6% | -1.2% | -56.7% |
| Pre-tax income | 0.6 | 0.8 | -1.4 | -3.6 | -4.1 | -4.3 | 0.3 | -10.8 |
| Income taxes | 0.1 | 0.1 | 0.1 | -0.3 | 0.1 | 0.2 | 0.1 | -0.3 |
| Tax rate | 20.6% | 15.0% | | 8.1% | | | 35.2% | 3.1% |
| Net income | 0.4 | 0.7 | -1.6 | -3.3 | -4.2 | -4.5 | 0.2 | -10.4 |
| Net margin | 1.7% | 2.4% | -8.0% | -19.7% | -24.7% | -24.2% | 0.9% | -52.2% |
| |
| Diluted EPS | $0.01 | $0.01 | ($0.04) | ($0.11) | ($0.15) | ($0.16) | $0.01 | ($0.38) |
| Shares outstanding (diluted) | 54.8 | 48.5 | 36.9 | 31.1 | 27.6 | 27.6 | 27.6 | 27.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|